Nicole Ammerman

Research Associate

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 14 Similar Profiles
Tuberculosis Medicine & Life Sciences
Clofazimine Medicine & Life Sciences
Mycobacterium tuberculosis Medicine & Life Sciences
Rickettsia Medicine & Life Sciences
Rickettsia typhi Medicine & Life Sciences
Rifampin Medicine & Life Sciences
Multidrug-Resistant Tuberculosis Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

Activity of a long-acting injectable bedaquiline formulation in a paucibacillary mouse model of latent tuberculosis infection

Kaushik, A., Ammerman, N., Tyagi, S., Saini, V., Vervoort, I., Lachau-Durand, S., Nuermberger, E. & Andries, K., Apr 1 2019, In : Antimicrobial agents and chemotherapy. e00007-19.

Research output: Contribution to journalArticle

Open Access
Latent Tuberculosis

Impact of clofazimine dosing on treatment shortening of the first-line regimen in a mouse model of tuberculosis

Ammerman, N., Swanson, R. V., Bautista, E. M., Almeida, D. V., Saini, V., Omansen, T. F., Guo, H., Chang, Y. S., Li, S. Y., Tapley, A., Tasneen, R., Tyagi, S., Betoudji, F., Moodley, C., Ngcobo, B., Pillay, L., Bester, L. A., Singh, S. D., Chaisson, R. E., Nuermberger, E. & 1 othersGrosset, J. H., Jul 1 2018, In : Antimicrobial Agents and Chemotherapy. 62, 7, e00636-18.

Research output: Contribution to journalArticle

Pharmaceutical Preparations
Multidrug-Resistant Tuberculosis

Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer

Converse, P. J., Almeida, D. V., Tasneen, R., Saini, V., Tyagi, S., Ammerman, N., Li, S. Y., Anders, N., Rudek-Renaut, M., Grosset, J. H. & Nuermberger, E., Aug 1 2018, In : PLoS Neglected Tropical Diseases. 12, 8, e0006728.

Research output: Contribution to journalArticle

Mycobacterium ulcerans
Buruli Ulcer

Clofazimine has delayed antimicrobial activity against Mycobacterium tuberculosis both in vitro and in vivo

Ammerman, N., Swanson, R. V., Tapley, A., Moodley, C., Ngcobo, B., Adamson, J., Dorasamy, A., Moodley, S., Mgaga, Z., Bester, L. A., Singh, S. D., Almeida, D. V. & Grosset, J. H., 2017, In : Journal of Antimicrobial Chemotherapy. 72, 2, p. 455-461 7 p.

Research output: Contribution to journalArticle

Mycobacterium tuberculosis
Pharmaceutical Preparations
In Vitro Techniques